Stockreport

CORRECTION: Athenex Announces Positive Second Cohort Results of Oraxol-plus-Ramucirumab Phase 1b Clinical Trial in Gastric Cancer

Athenex, Inc.  (ATNX) 
Last athenex, inc. earnings: 2/27 07:00 am Check Earnings Report
US:NASDAQ Investor Relations: ir.athenex.com
PDF BUFFALO, N.Y., Dec. 11, 2018 (GLOBE NEWSWIRE) -- In a press release issued under the same headline earlier today by Athenex, Inc., please note that the dosing regimen [Read more]